6-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 97.0%, 1g

4-Chloro-5-iodo-3-nitropyridin-2(1H)-one, 98%, 100mg

Pipeta microlitro monocanal Pipetman® G, 100 a 1000 µl, P1000G, 1 unidad

(3-phenyl-1,2,4-oxadiazol-5-yl)methanol, 95.0%, 1g

(5-Morpholinopyridin-3-yl)boronic acid, 95.0%, 250mg

1-isopropyl-4-nitro-1H-pyrazole-5-carboxylic acid, 5g

tert-Butyl 4-cyano-5,6-dihydropyridine-1(2H)-carboxylate, 95.0%, 100mg

Methyl 2-(Trifluoromethyl)benzoate>98.0%(GC)25g

(S)-2-(4-BROMOPHENYL)PYRROLIDINE, 95.0%, 250mg

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-isopropylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 1g

n-(2-Methoxyethyl)-4-nitrobenzenesulfonamide, 95%, 2g

Biphenyl-3-ylacetic acid, 95.0%, 5g

Methyl 6-oxo-1,6-dihydropyridazine-4-carboxylate, 95.0%, 250mg